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Triplet-mediated pyrimidine (Pyr) dimerisation is a key process in photochemical damage to DNA. 5 
It may occur in the presence of a photosensitiser, provided that a number of requirements are 
fulfilled, such as favourable intersystem crossing quantum yield and high triplet energy. The 
attention has been mainly focused on cyclobutane pyrimidine dimers, as they are by far the most 
relevant Pyr photoproducts obtained by sensitisation. The present perspective deals with the 
involved chemistry, not only in DNA but also in its simple building blocks. It also includes the 10 
photophysical characterisation of the Pyr triplet excited states, as well as a brief discussion of the 
theoretical aspects.  
 
1. Introduction 
Ultraviolet solar radiation reaching the Earth’s surface 15 
comprises wavelengths ranging from 290 to 320 nm (UVB) 
and 320 to 400 nm (UVA). Both UVB and UVA radiations 
have been demonstrated to induce mutations in DNA that are 
in the origin of skin cancer. This is a public health problem, 
aggravated by the increasing use of tanning sunbeds by the 20 
general public. Tanning lamps are intended to produce UVA, 
but they also emit marginally in the UVB. Recently (July 
2009) the International Agency for Research of Cancer 
(IARC) has declared these devices as “carcinogenic to 
humans”, since they have been proven to increase the risk of 25 
skin cancer by 75% when used by people under 30 years old.1, 
2 
 Although, in principle, longer-wavelength light is less 
dangerous, it has to be taken into account that defense 
mechanisms of the human skin towards their deleterious 30 
effects are less effective against UVA induced damage.3 
Actually, a number of reports have appeared on the 
promutagenic character of UVA radiation. Thus, studies 
performed on animals (opossum,4 fish,5 mice6) suggest that it 
provokes the formation of papillomas, squamous cell 35 
carcinomas (SCC) and melanomas; however, the role played 
by UVA-mediated oxidative damage to DNA in melanoma 
induction, using xiphophorus fishes as model, has been 
recently questioned.5, 7 
 While UVB is efficiently absorbed by the nucleobases, 40 
causing direct photoreactions of DNA, UVA-induced damage 
is commonly the result of photosensitisation. Thus, 
modifications in DNA may occur after light absorption by 
endogenous or exogenous chromophores present in drugs, 
cosmetic agents, metabolites, etc.  45 
 In this context, UVA-photocarcinogenesis has been mostly 
related to oxidative stress in early studies. Singlet oxygen 
production and to a lesser extent hydroxyl radical may be 
involved in the oxidation of guanine (the nucleobase with the 
lowest redox  50 
 
Fig.1 Exogenous photosensitisers acting as photocarcinogens 
potential), giving rise to 8-oxo-7,8-dihydro-2’-
deoxyguanosine (8-oxo-dGuo). However, cyclobutane 
pyrimidine dimers (CPDs) may also arise from UVA 55 
irradiation, and their formation yield is even larger than that 
of 8-oxo-dGuo in human skin.3, 8 This has been assessed by 
exposure of healthy human volunteers to UVA light and 
subsequent analysis of CPDs in their urine or skin.9, 10  
 While the promutagenic character of UVA light is 60 
established, the mechanism responsible for UVA 
photoinduced CPDs formation is a matter of discussion. In 
particular the possibility of direct UVA-photoinduced damage 
to DNA, in addition to photosensitisation by endogenous or 
exogenous agents, is still controversial.3, 8, 11-17 It has been 65 
claimed that CPDs may be formed after UVA irradiation of 
isolated or cellular DNA in the absence of a photosensitiser. 
However DNA hardly absorbs UVA, as required for a 
molecule to react (first law of photochemistry, Grotthus-
Draper law). As an alternative to direct DNA excitation, the 70 
presence of unknown chromophores or the insufficient purity 
of the UVA sources used in the experiments has been 
considered. Moreover, cellular DNA irradiations produce less 
CPDs in comparison with isolated DNA. As it is difficult to 
estimate the amount of light absorbed by DNA under these 75 
conditions, a contribution by endogenous photosensitisers (i. 
e. porphyrins, flavins, steroids, quinones) cannot be safely 
ruled out. 
 
 The aim of the present perspective article is to present the 
case of UVA-photosensitised damage to DNA, with special 
emphasis on the molecular mechanisms involved in the 
formation of CPD lesions. A better understanding of these 
processes should contribute to minimise the photobiological 5 
risk. 
 Among the exogenous agents reported to be 
photogenotoxic, phototumorigenic and photocarcinogenic in 
vivo, psoralens (used in the PUVA treatment of psoriasis)18-21 
and more recently fluoroquinolones (FQs), have received 10 
special attention (Fig. 1). The latter are widely used, broad 
spectrum antibacterial drugs. They are known to induce UVA-
mediated oxidatively damaged DNA,22-25 and their 
phototumorigenic potential has been proven in mice.26-29 
Irradiation of albino Swiss and skh-1 hairless mice with UVA 15 
light, varying the time of exposure and the drug doses, has 
established that fleroxacin (FLX) and lomefloxacin (LFX) are 
more potent phototumorigenic agents than 8-methoxypsoralen 
(8-MOP). Development of SCCs after the intake of FLX or 
LFX, together with other lesions such as benign papillomas, 20 
solar keratoses or kerato-acanthomas has also been observed 
in the rodents. Likewise, ofloxacin (OFX), ciprofloxacin 
(CPX) and the related compound nalidixic acid (NA) have 
also been found to enhance the development of skin tumours.  
 In vivo studies on xeroderma pigmentosum mice have also 25 
revealed LFX as a photocarcinogenic agent. These mice 
present an inefficient nucleoside excision repair activity for 
the enzymatic removal of CPDs29 while conserving the 
capability to repair oxidatively damaged DNA. Exposure of 
mice to low UVA doses insufficient to provoke severe 30 
phototoxic reactions, leads to a large number of SCCs after 
only 5 weeks; by contrast, control animals require 23 weeks to 
show similar effects. 
2. Photosensitised formation of cyclobutane 
pyrimidine dimers 35 
Photosensitised CPDs formation takes place through a formal 
[2+2] cycloaddition between the C5-C6 double bonds of two 
pyrimidines (Pyr). Thus, a photosensitiser (Phs) is excited 
upon light absorption and then transfers its energy to a 
pyrimidine base, giving rise to thymine or cytosine excited 40 
states (Thy* or Cyt*). These states are able to react with 
ground state Thy or Cyt leading to the final products 
(Schemes 1 and 2).  
 
Scheme 1 Key processes involved in photosensitised Pyr dimerisation 45 
 In general, sensitised photocycloadditions are known to 
proceed through a triplet-triplet energy transfer (TTET) 
process. As a consequence, a number of requirements should 
be fulfilled by the Phs of choice: i) to absorb light at longer 
wavelengths than Pyr, thus allowing for selective excitation, 50 
ii) to have a triplet energy above that of Pyr, as requested for 
thermodynamically  favoured  process  (Scheme 2), iii) to be  
 
Scheme 2 Interconversion between the excited states involved in 
photosensitised Pyr dimerisation 55 
chemically inert under the reaction conditions, avoiding 
formation of byproducts and consumption of the Phs, iv) to 
have a good intersystem crossing quantum yield (ISC) and a 
long triplet lifetime (T), in order to increase the probability of 
energy transfer to an acceptor, and v) to be close enough to 60 
the Pyr unit, thereby facilitating collision. 
2.1 Efficiency of photosensitised pyrimidine dimerisation 
In a TTET process, the energy transfer rate constant (kET) 
between the Phs (donor) and the Pyr (acceptor) depends on the 
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where kD is the diffusion rate constant in liquid solutions.
30 
 In this context, a favourable value of E is directly related 
to CPDs formation and therefore to the phototumorigenic 
capability of endo- or exogenous agents acting as Phs. Thus, it 70 
is of paramount importance to establish Pyr triplet excited 
state energies (3Thy*, 3Cyt*) to anticipate the potential of a 
compound to act as Phs. Consequently, an effort has been 
made in this sense, with special attention to 3Thy in DNA, 
where -stacking and base pairing can have a marked 75 
influence on the triplet excited state properties. 
 In addition to E and temperature18 (as inferred from eq. 
1), photoproducts formation and distribution are influenced by 
parameters such as the nature of the lowest lying triplet state 
of the Phs,31 the solvent,32 the concentration of Pyr used, etc. 80 
 The importance of Pyr concentration deserves a special 
comment. According to Scheme 1, ground state Pyr quenches 
both 3Phs* and 3Pyr*, so the reaction rates should increase 
with increasing Pyr concentration. In practical terms, 
photodimerisation quantum yields (D) are reproducible only 85 
upon complete quenching of the involved triplet excited 
states. Accordingly, only a limited number of D values are 
available (Table 1), due to the experimental difficulties to 
cover all the above requirements; they range between 10-2 and 
10-5. The values are consistent with the upper limit established 90 
by measurements performed using acetonitrile (0.02), where 
formation of cyclobutane thymine dimers (Thy<>Thy) is 





Fig. 2 Structures of all possible homodimers formed after UVA-photosensitised irradiation of Pyr 
 
2.2 Pyrimidine photoproducts in DNA building blocks 
In principle, Thy<>Thy, Cyt<>Thy, and Cyt<>Cyt dimers can 5 
be formed by photosensitisation of solutions containing the 
appropriate monomers. Different regio-and diastereoisomers 
may be obtained in solution (see Fig. 2).34 It is worth noting 
that the cis-anti and trans-syn isomers exist as enantiomeric 
pairs in Thy and Cyt and as diastereomeric pairs in thymidine 10 
(Thd) and 2-deoxycytidine (dCyd). Thus a total of 6 isolable 
diastereomeric homodimers can be obtained from the 
nucleosides, as compared with 4 in the case of the free 
bases.34, 35  
Although crossed cycloadditions are, in principle, possible to 15 
form Thy<>Cyt heterodimers, photosensitised formation of 
these CPDs has not been described. In this context, Thy 
dimers have received special attention, since they are the most 
abundant dimers formed in DNA.6, 8, 15, 36 
Table 1 Quantum yields of photosensitised pyrimidine dimerisation. 20 
Substrate Concentration Photosensitiser D














18.85 M in base 
pairs 







a In aqueous solution, bin ethyl acetate, toluene, methanol or acetonitrile 
solutions, cBP, benzophenone; PABA, para-aminobenzoic acid; DMT, 
dimethylthymine. 
 
2.2.1 Thymine and thymidine photosensitisation 25 
There are a limited number of compounds, including non-
steroidal anti-inflammatory drugs (NSAIDS), cosmetic agents 
like para-aminobenzoic acid (PABA), ketones or 
pyridopsoralens (PyPs), able to photoinduce CPDs formation 
in free nucleobases or nucleosides; among them PyPs and 30 
ketones are very illustrative examples (Fig. 3). 
 When pyridopsoralens with different triplet energies (ET), 
namely, pyrido[3,4-c]psoralen (H-PyPs, ET = 290.4 kJ/mol), 
7-methylpyrido[3,4-c]psoralen (MePyPs, ET = 288.5 kJ/mol) 
and 7-methylpyrido[4,3-c]psoralen (2N-MePyPs, ET = 281.7 35 
kJ/mol) are irradiated in thin films in the presence of Thy, 
Thy<>Thy dimers are obtained with the cis-syn isomer as the 
most abundant one.18 Products yields correlate with the PyPs 
triplet energies, as expected from Sandros’ equation. 
Furthermore, parallel irradiations with the related compounds 40 
5-methoxypsoralen (5-MOP, ET = 268.2 kJ/mol) and 8-MOP 
(ET = 260.5 kJ/mol) show very little if any photosensitised 
dimer formation. 
 A clear example of the temperature effect is provided by an 
experiment performed with H-PyPs. Photoinduced Thy<>Thy 45 
formation at 77K is two orders of magnitude less efficient 
than at 300K. Photosensitisers with ET lower than that of 
3Pyr*18, 42, 43 can still work upon thermal population of the 
3Phs* upper vibrational states. Even if formed in low yields, 
the resulting CPDs would be of biological significance.18, 31 50 
  In this context, distribution of the photodimers mixture can 
be influenced by the polarity of the solvent. Thus, 
benzophenone (BP) photosensitisation of 1,3-dimethylthymine 
(DMT) leads to the cis-syn isomer as major photoproduct in 
polar solvents (~ 72%, CH3CN and CH3OH) while in non-55 
polar solvents the cis-anti one predominates (~50 %, 
benzene).32, 39  
 Ketones have often been used to photosensitise CPDs 
formation taking advantage of their high ISC (nearly1).
32, 37, 
44-49 Irradiation of aqueous solutions of Thy (or Thd) in the 60 
presence of acetone, propiophenone, acetophenone or 
benzophenone gives rise to a mixture of isomers (Fig. 2), with 
certain prevalence of the trans-anti diastereomers.44, 46-48 
 
 
Scheme 3 Mechanistic pathways involved in the photosensitised 
oxidation of thymidine by benzophenone 
 Interestingly, ketones can also mediate oxidation of Pyr 
bases given their ability to participate in hydrogen abstraction 5 
or electron transfer processes50 (Scheme 3). Nonetheless, in 
the case of dinucleotides such as TpT48 energy transfer 
prevails (ca. 94 %) over BP-photosensitised oxidation. 
 
2.2.2 Cytosine and 2-deoxycytidine photosensitisation 10 
Although early attempts to photosensitise Cyt<>Cyt formation 
with BP, acetone or acetophenone were unsuccessful,37 later 
work has reported on three dimers of Cyt/dCyd in aqueous 
acetone (trans-anti, cis-syn and cis-anti, Fig. 2).35 This type of 
photoproducts have not attracted special attention, since their 15 
photosensitised formation in DNA occurs with comparatively 
low yields (see below); however Cyt containing CPDs are 
biologically relevant due to their high mutagenic potential. 
Besides, Cyt dimers deaminate easily when formed, giving 
rise to complex mixtures of dimers with random combination 20 
of Cyt and uracil (Ura) units. Interestingly, nucleoside 
deamination has been found to be six times faster than that of 
the nucleotide. 
 
2.2.3 Byproducts of the photoreaction of triplet sensitisers 25 
with pyrimidines 
As stated above, a Phs must be chemically inert. Otherwise, 
secondary reactions can occur giving rise to misleading 
results, such as formation of byproducts and overestimation of 
the photoreaction quantum yields. This is the case of PyPs and 30 
ketones (Fig. 4).  
 For example, PyPs possess a double bond in their furan 
moiety prone to react through a [2+2] cross-
photocycloaddition with the C5-C6 double bond of Pyr. 
Actually, when CPDs formation is photosensitised by PyPs, 35 
this type of photoaddition is indeed observed.19 Likewise in 
the acetone photosensitised reaction of Thd an acetonyl 
derivative has been isolated as a side product.34 
 Furthermore, carbonyl compounds may in principle react 
with alkenes to form oxetane derivatives through a [2+2] 40 
photocycloaddition (Paterno-Büchi reaction). This process is 
favoured when i) the triplet energy of the alkene is 
comparable to (or higher than) that of the carbonyl compound  
and ii) the lowest lying carbonyl triplet state is of nnature. 
As a consequence, ketones with relatively low triplet energy 45 
may lead to oxetane derivatives of Pyr, in addition to CPDs.51-
53 This is the case of BP:31,44 its triplet excited state, which 
presents a nconfiguration, has an ET level below that of 
acetone or acetophenone. As a matter of fact, a Paterno-Büchi 
reaction giving rise to oxetanes is favoured versus TTET 50 
(Scheme 4). Only when Thd is present at high concentrations 
CPDs are obtained.31, 50 Similar observations have been 
reported for NSAIDs containing the BP chromophore, such as 
ketoprofen (KP) and its derivatives.51, 52, 54, 55 Similarly, a 
photocycloaddition product identified as an oxetane has been 55 






Fig. 3 Photosensitisers for Pyr dimerisation 
 
 
Fig. 4 Structures of byproducts obtained upon photosensitisation of Thd 
with PyPs (left) or acetone (right). 
 
Scheme 4 Paterno-Büchi photoreaction between BP and Thd. 5 
2.3 Oligonucleotides photosensitisation 
Photosensitised CPDs formation has been observed in 
oligonucleotides and single stranded DNA (ss-DNA). Here, 
Pyr dimerisation occurs through adjacent Pyr on the same 
strand, inducing a distortion in the structure. Among the 10 
possible cyclobutane dimers, 5’-Thy<>Thy-3’, 5’-Cyt<>Thy-
3’ and 5’-Thy<>Cyt-3’ are preferentially promoted. However, 
5’-Cyt<>Cyt-3’ may be obtained in lower yields.6 Since Cyt is 
the DNA base with the highest triplet energy, a reduced 
number of photosensitisers can be involved in a 15 
thermodynamically favourable TTET. Furthermore, if a 
fraction of Cyt reaches the triplet excited state, efficient 
deactivation by energy transfer to the other bases should be 
expected.36  
 In addition, Thy<>Thy predominate over Thy<>Cyt dimers 20 
in oligonucleotides and DNA.56 For instance, acetophenone-
mediated photodimerisation of thymidylyl-(3’-5’)-thymidine 
(TpT, Scheme 5) occurs five to six times faster than that of 
thymidylyl-(3’-5’)-deoxycytidine (TpdC).57 The energy gap 
values in terms of Sandros’ equation (eq. 1), together with the 25 
relative reactivity of 3Thy towards Cyt or Thy, would explain 
the different photodimerisation rates. 
  Orientation restrictions imposed by the sugar- 
phosphodiester backbone prevent formation of the anti forms 
and favour the cis-syn arrangement;19, 35, 48, 55-59 nonetheless, 30 
trans-syn dimers are also observed in ss-DNA or 
 
Scheme 5 Photosensitised  thymidylyl-(3’-5’)-thymidine (TpT) 
dimerisation 
oligonucleotides owing to their flexible structure.56, 60 This is 35 
the case of dCpT, TpdC and TpT, which produce mainly cis-
syn and trans-syn diastereomers48, 61 in proportions that may 
range from 7:1 (TpT) to 3:1(dCpT) or 1:1 (TpdC). Similar 
results are obtained when two Thy units are kept in close 
proximity through a polymethylene linker.62 The largest 40 
Thy<>Thy yield is obtained in the case of Thy-(CH2)3-Thy, 
likely because the angle between the two Thy approaches that 
in DNA. Only the intramolecular photodimerisation of some 
N-acetylated dinucleotides gives rise exclusively to the trans-
syn configuration, presumably due to steric hindrance.63  45 
 The influence of the Thy-Thy distance has also been 
evaluated by comparing the reaction rates and hy<>Thy 
formation yields of poly(T) and depurinated poly(dA-T). In 
both cases, Thy<>Thy dimers are formed, albeit the reaction 
rate is slowed down in the latter due to the poorer -stacking 50 
and longer base-to-base distance. Conformation has a 
pronounced effect on CPDs formation by governing the extent 
of stacking between the bases. This is further supported by the 
fact that dimerisation efficiency is reduced after denaturation 
by addition of a suitable solvent like ethanol.36, 64, 65 55 
 The outcome of dimerisation does not only depend on the 
conformation but also on the nucleobases sequence.66 The 
frequency of CPDs lesions increases when a Pyr is located in 
the 5’ side of two consecutive Thy.56, 67-70 Studies performed 
by means of 32P radiolabelling and subsequent electrophoresis 60 
combined with specific DNA repair enzymes, have shown that 
photosensitised Pyr<>Pyr formation in a 25-mer 5’-TGA 
GCG TTA GTT TAA GTC GGC TATC-3’ by ketonic drugs 
occurs more frequently in TTT fragments. 
2.4 DNA photosensitisation 65 
While UVA-photosensitisation of DNA gives rise exclusively 
to CPDs, direct UVB irradiation also produces pyrimidine (6-
4) pyrimidone photoproducts.16 This strongly suggests the 
involvement of two different mechanisms.  
 As in oligonucleotides, DNA photosensitisation produces 70 
Thy<>Thy, 5’-Cyt<>Thy-3’ and 5’-Thy<>Cyt-3’, together 
with small amounts of Cyt<>Cyt in adjacent pyrimidines on 
the same strand, with an overwhelming predominance of cis-
syn Thy<>Thy. Analysis of these lesions is often performed 
by radiolabelling and subsequent electrophoresis.25, 71, 72 75 
Single cell electrophoresis (comet assay) has been 
successfully used to reveal cellular DNA damage, as 
fragmented DNA moves faster through the agarose gel, 
forming a tail.73, 74 Both methods can be combined with 
specific repair enzymes to reveal the type of damage 80 
produced.  
 Relative Pyr<>Pyr formation yields are listed in Table 2. 
For example, irradiation of DNA using BP or acetophenone as 
Phs does not produce detectable amounts of Cyt<>Cyt. Only 
acetone photosensitisation leads to Cyt homodimers,8, 56, 75, 76 85 
presumably due to the higher ET. In general, 5’-Cyt<>Thy-3’ 
and 5’-Thy<>Cyt-3’ photosensitisation is inefficient as 
compared to Thy<>Thy, although in ct-DNA and coliphage 
M13 considerable amounts of heterodimers are obtained. For 
comparison, in direct DNA photolysis the relative formation 90 
yields are 1:0.8:0.2 (TT:CT:CC).36 
 
Table 2 Relative Pyr<>Pyr formation yields after UVA irradiation of different types of DNA in the presence of ketones 
 BPa  Acetophenonea,b,c,d,e  Acetonee,f 
 a  a b c d e  e f 
Thy<>Thy 0.2  1 1 1 1 0.65  1 1 
Thy<>Cyt 0.046  0.24 
0.05 0.19 0.03 *n.d  0.12 
0.20 
Cyt<>Thy 0.05  0.23 0.36 
Cyt<>Cyt *n.d.  *n.d. *n.d. *n.d. <0.003 *n.d.  0.05 0.08 
aCalf-thymus DNA,8 bnative DNA,64 cdenatured DNA,64 dE. coli DNA,41 e Phage T777 and fColiphage M13 mp2,56 *n.d. = Not determined. For each 
experiment, the amount of Thy<>Thy has been set as the unity for comparison. 
 
 Formation of CPDs in isolated and cellular DNA can be 5 
photosensitised not only by ketones,58, 76 but also by PyPs,19, 
78 NSAIDs,40, 54, 68, 79 FQs,23, 25, 29, 71-74, 80, 81 amino acids and 
derivatives59, 82 or cosmetic agents83, 84 (Fig. 5). Studies 
performed on Thy dimerisation by the FQ family have played 
a key role in determining the triplet energy of Thy in DNA at 10 
ca 267 kJ/mol. Dimers formation is mediated by ENX and 
NFX, while it is not by the N(4')-acetyl NFX derivative 
(ANFX) or OFX.23, 25, 71, 72 Interestingly, for ENX, LFX and 
NFX the efficiency of CPDs formation has been found to be 
different in isolated and cellular DNA. 15 
 As in oligonucleotides, Thy<>Thy formation in DNA is 
sequence-dependent.19, 56, 69, 78 Pyridopsoralens H-PyPs, 
MePyPs and 2N-MePyPs react specially at TTTTA and 
TTAAT fragments, provoking 40% and 55% of Thy<>Thy 
photolesions, respectively. Moreover, CPDs formation is not 20 
detected in a GC environment or at CC sites.  
 In addition to neighbouring effects, sequence dependence 
may be the result of selective formation of Phs-DNA 
complexes in specific DNA locations. Thus, complexation to 
DNA can place the Phs and the Pyr units in close proximity 25 
favouring TTET processes. As an example, 4’,5’-dihydro-7-
methylpyrido[3,4-c]psoralen, a modified PyPs, binds to DNA 
close to 5’-TA-3’ sites.78 If the binding is disrupted (i.e. by 
varying the ionic strength), Thy dimers formation is 
negligible.82 An additional example is provided by two 30 
cationic derivatives: -dimethylaminopropiophenone 
hydrochloride and N-(m-acetylbenzyl)-N-(2-aminoethyl) 
ammonium dichloride. The charged Phs are brought close to 
DNA by ionic interactions, which is reflected in an increased 
photosensitisation capability with respect to acetophenone.41 35 
 
Fig. 5 Photosensitisers for Pyr<>Pyr formation in DNA 
 
3. Spore photoproducts 
Another interesting dimeric pyrimidine lesion corresponds to 40 
the most abundant UV photoproduct in bacterial spores.85, 86 
Indeed, 5-thyminyl-5,6-dihydrothymine adduct, the so called 
spore photoproduct (Fig. 6, SP), is formally obtained by 
linking the allylic carbon to the C5 position of a neighbouring 
Thy, with saturation of the C5-C6 double bond. Four isomeric 45 
forms of SP may be formed within DNA since a chiral center 
is generated at C5a carbon. Furthermore, the allylic carbon 
can be linked to adjacent thymines located  
 
Fig. 6 Structures of SP photoproduct and of dipicolinic acid 50 
either at the 3´- or at the 5´-end. Interestingly, DNA double 
helix structure induces a highly stereospecific formation of SP 
photoproducts (Fig. 6);87 their stucture has been recently 
assigned by 2D NMR studies combined with DFT 
calculations. Thus, the natural SP results from addition of the 55 
thymine methyl group located on the 3´-end to the thymine C5 
carbon located in the 5´-end, giving rise to a new chiral center 
with R absolute configuration.87 Moreover, SP is only 
obtained as a Thy homodimer and has been detected both as 
intrastrand and interstrand lesion.88, 89 60 
Indeed, SP is a quite peculiar bipyrimidine photoproduct, 
whose formation has been related to three important factors:85, 
89, 90 i) the low hydration level in spore core, ii) the binding 
of/ type small, acid soluble protein (SASP), which converts 
DNA from B-like to A-like conformation, and iii) the 65 
presence of dipicolinic acid (pyridine-2,6-dicarboxylic acid 
DPA, Fig. 6) in the spore core (up to 10% of dry weight). The 
 
Scheme 6 Mechanism postulated for SP formation. 
 
photosensitising properties of this endogenous compound 
have been first proposed on the basis of the decrease of SP 
formation yield in spore strains lacking DPA.88, 91 This 
hypothesis has been further supported by studies in less 
complex media like isolated DNA, TpT or Thd.49, 87-89, 92, 93 In 5 
this context, UVC irradiation of DNA dry films in the 
presence of DPA has revealed the increase of SP, Thy<>Thy, 
and to a lesser Thy<>Cyt and Cyt<>Thy relative yields,85, 88, 
91 whereas Cyt<>Cyt and (6-4) photoproducts yields remain 
almost unchanged. These data are in agreement with the role 10 
of DPA as triplet photosensitiser, acting as donor in TTET 
processes. Further pieces of evidence supporting the 
feasibility of such a process have been provided by the results 
of UVA-irradiation of Thd dry films in the presence of BP or 
three pyridopsoralen derivatives (H-PyPs, MePyPs and 2N-15 
MePyPS, Fig. 3).19, 49 In these experiments, the six 
diastereoisomers of Thd<>Thd and the 5R*/5S* 
diastereoisomers of SP have been detected; their yields have 
been shown to depend on the nature of the photosensitiser.19 
As expected for triplet energy donors, their efficiency can be 20 
related to their excited state level, with H-PyPs being the most 
efficient, followed by MePyPs and 2N-MePyPs. Accordingly, 
no formation of Thd<>Thd and SP has been observed for the 
donors with lower triplet energy like 3-carbethoxypsoralen, 5-
methoxypsoralen and 8-MOP.19  25 
 Finally, it is noteworthy that in spite of the interesting SP 
photochemistry, the involved mechanism has not been 
investigated.85, 94 The reaction may occur by coupling of the 
5-thyminyl /5,6-dihydrothymin-5-yl radical pair generated as 
a result of H-abstraction from a ground state by a triplet 30 
excited Thy (Scheme 6). Alternatively, a concerted 
mechanism involving the methyl group of one Thy and the 
double bond of the second Thy has been proposed. Either the 
shorter lifetime  of radical pairs (as compared with the free 
radicals generated by radiation)95, 96 or the concerted nature of 35 
the process would account for the observed stereoselectivity. 
4. Theoretical calculations 
In spite of their importance in DNA damage formation, the 
Pyr triplet excited states are only now starting to be analysed 
by theoretical studies.97-108 First principles calculation 40 
methods converge on the * nature of the lowest triplet state 
but not on their energy values, which have been reported over 
a large range (Table 3) depending on the method used for 
calculation and geometry optimisation. So far, the highest 
level of approach has been CASPT2 based on CASSCF wave 45 
functions. However, because of the difficulties to apply this 
methodology for large molecules, a number of calculations 
have been performed at the density functional theory (DFT) 
level or by using the coupled cluster (CC) model. 
 In this context, the vertical excitation energy for Thy at the 50 
ground state geometry is situated between 336.7 and 382.1 
kJ/mol (3.49 eV and 3.96 eV), while adiabatic excitation 
energy values range from 272.1 to 304.9 kJ/mol (from 2.82 to 
3.16 eV). Similar discrepancies have been reported for Cyt 
and Ura (Table 3). Nevertheless, the general trend extracted 55 
from the calculated values is in agreement with the 
experimental data, i.e. the nucleobase with the lowest triplet 
excited state energy is Thy, while the highest triplet manifold 
corresponds to Cyt. Recently, the energetic gap between 3Thy* 
and 3Ura* has been rationalised in terms of the influence of 60 
C5-methylation. This substitution induces an up-shift of the  
HOMO while the acceptor * LUMO is almost unaffected, 
thus resulting in a red shifted * transition.100  
Table 3 Vertical and adiabatic * (singlettriplet) transition energy 
calculated for isolated Thy, Cyt and Ura and for their excimers (Pyr-Pyr). 65 
Values are given in kJ/mol and in eV in parentheses. 
 Vertical Adiabatic 
Thy 
336.7-337.7 (3.49-3.50)a 97 
366.6-377.3 (3.80-3.91) b 97 
272.1-275.0 (2.82-2.85)a 97 
288.5-296.2 (2.99-3.07) b 97 
299.1-304.9 (3.10-3.16)c 98 
358.9-372.4 (3.72-3.86) c 98 
341.6 (3.54) a 98 
373.4 (3.87) c 100 
376.3 (3.90 ) c 100 hyd, 
382.1 (3.96) c 100 aq 
285.6 (2.96) a 98 
296.2 (3.07) c 100 
 
346.4 (3.59)d 99 
368.6 (3.82)c 107 




274.6-275.5 (2.84-2.85) a 102 
227.7 (2.36)d 103 
Cyt 347.3- 350.2 (3.60-3.63)a 97 
361.8-383 (3.75-3.97)b 97 
 
352.2 (3.65)d 101 
330.0-352.2 (3.42-3.65) a 105 
361.8-383.0 (3.75-3.97) b 105 
340.6 (3.53)d 106 
374.4 (3.88)c 107 
293.3-298.1 (3.04-3.09)a 97 
302.0-311.6 (3.13-3.23)b 97 
 
293.3 (3.04) d 101 
284.6-298.1 (2.95-3.09) a 105 
302.0-311.6 (3.13-3.23) b 105 
287.5 (2.98)d 106 
 




284.6-383.0 (2.95-3.97) a 97 
287.5-419.7 (2.98-4.35) b 97 
 370.5-383.0 (3.84-3.97) c 98 
367.7 (3.78) a 98 
312.6-319.4 (3.24-3.31) c 98 
302.0 (3.13) a 98 
 384.0 (3.98) c 100 
387.9 (4.02) c 100hyd 
395.6 (4.10) c 100aq 
309.7 (3.21) c 100 
 
 366.6 (3.80)d 108 
379.2 (3.93)c 107 
303.9 (3.15)d 108 
 
Ura-Ura  238.3 (2.47)d 103 
Calculated using a DFT, b CCSD, c CC2, d CASPT2//CASSCF 
Scheme 7 Triplet mediated formation of Pyr<>Pyr. Adapted from 
Serrano et al 103 70 
 
Computational studies are generally performed in vacuo i.e. 
without taking into account interaction between the target 
molecules and solvent. However, it is well established that 
such interactions may have a marked influence on the excited 
state energy. In this context, the combined effect of hydration 5 
(energies denoted as hyd, Table 3) and solvent polarity, used 
to mimic aqueous environment (denoted aq in Table 3) has 
only revealed a slight destabilisation of the lowest 3* triplet 
state of Ura and Thy.100, 109 Concerning the photochemical 
reactivity of Pyr, theoretical calculations have mainly focused 10 
on the formation of cyclobutane dimers in a concerted process 
from the singlet excited state.110-114 However, as stated above, 
in the case of photosensitised Pyr<>Pyr formation, [2+2] 
photocycloaddition occurs from the triplet manifold. In spite 
of its importance, up to now this reaction pathway has only 15 
been considered by two research teams.102-104 In a first 
approach, calculations at the TD-DFT level have shown that 
triplet mediated photocycloaddition of Thy proceeds through 
an initial C6-C6´ bond formation, leading to a biradical 
intermediate that subsequently crosslinks to the singlet 20 
surface, giving rise to Thy<>Thy.102 More recently, 
Pyr<>Pyr formation has been computed by means of high 
level quantum chemical CASPT2//CASSCF calculations.103, 
104 For a better approach to the nucleobase properties in DNA, 
the triplet minima have been calculated for excimer 25 
arrangements formed by the parallel stacking of the bases 
(Scheme 7). In this context, a stabilisation relative to the 
isolated bases (denoted 3Pyr*+Pyr in Scheme 7) is observed, 
giving rise to adiabatic energy values of 2.36, 2.47, 2.70 eV 
for Thy, Ura, and Cyt, respectively. This triplet excimer 30 
connects without any energy barrier with a stepwise 
intermediate 3(SWI), which exhibits a biradical character. 
Indeed, a covalent bond is formed between the C6 and C6´ 
carbons, with the unpaired electrons and spin density located 
on the two other ethylenic carbons (C5 and C5´). At this 35 
stage, the calculated C6-C6´ bond lengths are 1.669, 1.660 
and 1.664 Å for Cyt, Ura, and Thy; by contrast, the 
interatomic C5-C5´ distance is elongated (about 2.8 Å). 
Finally, 3(SWI) corresponds to a singlet-triplet crossing 
(T1/S0)x structure leading to Pyr<>Pyr ground state.  40 
 Thus, the efficiency of Pyr<>Pyr photosensitisation 
depends on two factors. The first one is the effectiveness of 
the TTET process from the 3Phs*, which is related with the 
triplet state energy of the nucleobase (3Cyt*>3Ura*>3Thy*); 
this agrees with the experimental predominance of Thy<>Thy 45 
dimers vs. other Pyr combinations. The second factor deals 
with the efficiency of the intersystem crossing process toward 
the ground state of the photoproduct (T1/S0)x. 
 




Thymine and its derivatives exhibit a pH-dependent 
phosphorescence emission. At 77 K under neutral conditions, 
no signal is observed for diluted aqueous solutions.115-117 55 
Conversely, at a pH higher than the pKa of Thy (ca. 9.6),118 
the nucleobase in its anionic form emits at 445 nm with a 
decay time of 0.4-0.5 s.115, 119, 120 Parallel experiments have 
reported that at neutral pH and high concentrations (i. e. 10-3-
10-2 M), formation of aggregates gives rise to a 60 
phosphorescence emission at 470 nm, with a lifetime of 0.2 s 
(Table 4).42, 118 A similar spectrum has been detected by 
photosensitisation experiments using acetone to populate the 
Thd monophosphate (TMP) triplet excited state by an energy 
transfer mechanism.42, 120 Emission of Cyt and its derivatives 65 
has been studied to a lesser extent;43, 120-125 the obtained data 
are listed in Table 4. 
 Thus, as shown in Figure 7, Thy and Cyt are the 
nucleobases with the lowest and the highest triplet excited 
state energies, respectively. 70 
 An intriguing result is the reported phosphorescence 
emission of native DNA. Indeed, by considering the higher 
phosphorescence quantum yield of purines, an overall 
emission closely related to these bases could be expected. 
However, the DNA spectrum does not exhibit the well-75 
structured band characteristic of purines, and the obtained 
quantum yield (Table 4) is 1 order of magnitude lower than 
that of adenosine monophosphate (AMP) or guanosine 
monophosphate (GMP). Hence, it has been proposed that 
DNA emission arises from the triplet level of Thy residues. 80 
Accordingly, a more intense phosphorescence has been 
monitored for DNA with higher adenine (Ade) + Thy 
contents.42, 126 Different hypotheses have been postulated to 
explain the nature of the emissive residues. On the basis of the 
lack of phosphorescence found for isolated Thy, emission was 85 
initially attributed to that of Thy anion formed by transfer of 
the thymine N3 proton across the Watson-Crick base pairing 
to the N1 nitrogen of adenine.115, 119 Nevertheless, this 
hypothesis has been contradicted by the phosphorescence 
emission of Thy aggregates, which closely resembles that of 90 
DNA. This assignment has been further supported by the Thy-
like emission of 1,3-dimethylthymine in the presence of Ade, 
where the proton transfer is not possible.118, 127 A similar 
conclusion has been drawn from single stranded DNA studies. 
42 Different explanations have been provided to account for 95 
the fact that Thy is the only emitting residue in DNA. The 
first one is related to its relatively low triplet state energy. It 
has been reported that, irrespective of the excited 
chromophore (Ade, Gua, Thy or Cyt), the only emission 
observed in solutions containing mixtures of the nucleobases 100 
is that of 3Thy*. 118, 120, 127 This is consistent with energy 
transfer from the higher lying triplet excited states of Cyt, 
Ade or Gua to Thy in solution. Accordingly, a thymine 
emission has also been obtained for the dinucleotides dApT 
and TpdA but also for polydAT. 42, 115, 119, 120, 126, 128A similar 105 
deactivation channel towards 3Thy* has been postulated to 
explain the case of the whole DNA biomacromolecule.118, 127 
 
Table 4 Phosphorescence emission properties of pyrimidines, 
oligonucleotides and DNA at 77K. If not specified the values correspond 
to ethylene glycol/water glass at neutral pH. 





0.075 a 129 
<0.008122 
0.00643 
0.018-0.015 a 129 
Thd 
470b 127 







0.038-0.042 a 129 
















0.3 42, 115, 119, 126 
0.3g119 
0.5 d 123 
0.002 115, 119 
≤ 0.02122 
Cyt 430e 123 
















dCpdC   0.01120 





a 2-methyltetrahydrofuran, b In H2O pH 7; 
c in CH3CH2OH; 
d : 0.25% 
glucose in 0.1M sodium acetate-H2O,
 e isopropanol/isopentane, f H2O 5 
/propylene glycol 1/1, g H2O, 
h CH3OH/H2O 1/9 pH 7. 
 
 On the other hand, for the Gua – Cyt base pair, proton 
transfer at the singlet level can also be in the origin of their 
lack of emission.118, 119 Expectedly, DNA structure integrity is 10 
an important parameter. Temperature, solvent or pH 
conditions leading to denaturation of the double helix result in 
the typical blue shifted, more structured and longer lived 
phosphorescence emission of purines.119, 126 
5.2 Laser flash photolysis studies 15 
5.2.1 Intrinsic population of the triplet excited state upon 
direct excitation of Pyr bases 
Time-resolved techniques have been used to study the 
photophysical properties of singlet and triplet excited states of 
individual nucleobases, nucleosides, nucleotides and 20 
oligonucleotides.130-142 In this context, it is generally accepted 
that the mechanisms involved in the generation of CPDs upon 
direct excitation of Thy are initiated by population of a singlet 
* state;138, 139, 141 however, the nature of the subsequent 
steps still remains a matter of discussion. Recent studies 25 
performed on Thd and (T)20, using ultrafast time-resolved 
fluorescence and transient absorption spectroscopy, suggest 
that the * triplet excited state is a key player in the 
dimerisation reaction. Thus, similar spectra (with maxima at 
350-400 nm) are obtained for both Thd and (T)20.
136, 141, 142 30 
They have been safely assigned to the T-T transition, which 
fully develops within picoseconds. The ISC quantum yield in 
aqueous solution has been estimated to be in the range 0.01-
0.03, with a higher value for (T)20 than for Thd. The main 
difference observed between the nucleoside and the 35 
oligonucleotide concerns the triplet lifetimes. Thus, T values 
in the subnanosecond domain have been determined for (T)20; 
by contrast, 3Thd survives in the ns-s timescale, with a 
concentration-dependent lifetime. The role of triplet-mediated 
CPDs formation in (T)20 supports a major contribution of this 40 
pathway also in natural DNA, where an extremely short T 
value would account for the previously reported inefficient 
quenching of CPDs formation by oxygen. Interestingly, the 
quantum yield of Pyr<>Pyr photodimerisation in double-
stranded genomic DNA is ca. 30 times lower than in (T)n 45 
oligonucleotides.3, 138, 139 Light absorption by non-thymine 
bases, low frequency of Thy doublets, and conformational 
restrictions may be in the origin of this effect.  
 Table 5 shows a selection of key photophysical parameters 
(ISC quantum yield, as well as rate constants for unimolecular 50 
decay and self quenching, k0), determined for the triplet 
excited state of the Thy chromophore in the free base and in 
some derivatives. It also includes the corresponding molar 
absorption coefficients of the T-T absorption (T), which have 
been obtained applying an energy transfer method, with 55 
retinol as acceptor.130 The data indicate that formation of the 
triplet excited states upon direct UV-irradiation occurs 
actually in all cases. In spite of its biological relevance, the 
efficiency of this process is low, particularly in aqueous 
medium.  60 
 
Table 5 Photophysical properties of the triplet excited state of Thy and its 
derivatives in different solvents 
 Solvent T (M
-1cm-1) 
at 370 nm141, 
143 
ISC /        
10-2 141, 143 
k0 (s
-1) /  
105 136, 143 
kS (M
-1s-1) / 
108 136, 143 
Thy 
CH3CN 2700  6.0 0.7-2.2 5.3-7.0
 
H2O 3500  0.6 0.2 7.9 
Thd 
CH3CN 3600  6.9   
H2O 3600  1.4 0.4 1.0-1.9 
TMP 
CH3CH2OH 4000  5.5  2.0 
H2O 3500  0.8-1.5 0.4 0.2 
(T)20 H2O 2700  2.8  100
a 




 As stated above, triplet quenching by the ground states is 
associated with Pyr<>Pyr dimerisation. Its rate constant can 
be determined according to: 
 0 0   obs Sk k k S    (2) 
where ks stands for unimolecular decay and self quenching, 5 
respectively. As a matter of fact, the obtained values show 
that both deactivation pathways can compete, depending on 
the experimental conditions (solvent, concentration, etc.). It is 
worth noting that the highest kS corresponds  to the 
oligonucleotide, as expected for a concentration-independent 10 
process. A similar situation can be anticipated for natural 
DNA. 
 By contrast with Thy derivatives, the triplet excited states 
of Cyt, dCyd and dCyd monophosphate (dCMP) have not 
been observed upon direct photolysis; this can be atributed to 15 
the low ISC quantum yields and molar absorption 
coefficients.133  
 
5.2.2 Photosensitised generation of Pyr triplets 
A number of time-resolved studies have been performed on 20 
photosensitised reactions of Pyr bases, either alone or as 
substructures of more complex entities (nucleosides, 
nucleotides, oligonucleotides, etc.). In this context, Pyr 
dimerisation has been shown to occur via the triplet excited 
state, using sensitisers such as acetone, acetophenone and 25 
propiophenone (Fig. 3).37, 132-136 Acetone is particularly 
advantageous over other triplet sensitisers in kinetic studies 
for several reasons. First, acetone has a very high triplet 
energy (ET ca. 330 kJ) and hence it can photosensitise both 
Thy and Cyt bases. Second, its ISC quantum yield is close to 30 
the unity, so it is two orders of magnitude higher than those 
described for Pyr derivatives. Finally, the triplet-triplet 
absorption band of acetone does not interfere with observation 
of the growth of Pyr triplet excited states at 400 nm, and does 
not overlap with their whole transient absorption spectra (see 35 
Figure 8).133, 136  
 After excitation of the photosensitiser, a number of 
processes may occur. The initial step is formation of the Phs 
first singlet excited state (1Phs*). At this point, several 
pathways can compete: fluorescence and internal conversion 40 
lead back to Phs, while intersystem crossing affords the triplet 
excited state (3Phs*). An ideal photosensitiser should have an 
ISC quantum yield close to 1. 
 The Phs triplet energy relative to that of the Pyr derivative 
is a key point to predict whether energy transfer can proceed. 45 
Thus, for irreversible energy transfer, the triplet energy of the 
donor must be at least 12 kJ/mol higher than that of the 
acceptor.135  
 In this context, the interaction between a variety of ketone 
triplets and mononucleotides has been studied as a function of 50 
the relative energies of the Phs-nucleotide pair. While ketones 
with ET higher than 305 kJ/mol (acetone, acetophenone, 
propiophenone and 1-indanone) sensitise the generation of a 
transient absorption corresponding to 3TMP* in laser flash 
photolysis (LFP), those with ET < 305 kJ/mol do not exhibit 55 
any triplet sensitisation capability, in spite of the significant 
quenching experimentally observed (kq > 10
8 M-1 s-1).134  
Fig. 8 Transient absorption spectrum of triplet excited of TMP, obtained 
by energy transfer from acetone in deaerated aqueous solutions.134 60 
 
Fig. 9 Triplet energy of photosensitisers and electrophoretic analysis of 
DNA Form I (supercoiled native form) and Form II (single strand break) 
obtained from mixtures containing pBR322 and FQs (20 M) after 15 min 
of irradiation and subsequent T4 Endo V treatment. Adapted from 65 
Lhiaubet-Vallet et al.72 
 Hence, the absolute value of TMP triplet energy has been 
estimated at ca. 310 kJ/mol. According to the Sandros’ 
equation, this is consistent with the observation of energy 
transfer from acetophenone (ET = 310 kJ/mol), but not from 3-70 
methoxyacetophenone (ET = 303 kJ/mol).
135 
 Benzophenone derivatives, with ET = 290 kJ/mol, lower 
than that of TMP, have been shown to photosensitise 
Thd<>Thd formation at high nucleoside concentrations, in 
competition with a more favoured Paterno-Büchi 75 
photocycloaddition.31 This explains the efficient quenching 
(kq.= 5.1 x 10
8 M-1 s-1) observed in acetonitrile. Remarkably, 
LFP studies on (S)- and (R)- KP have shown a significant 
enantiodifferentiation in the quenching rate constants by 
Thd.55 80 
 In DNA, the photosensitiser triplet energy required for 
Pyr<>Pyr formation has been progressively shifted from ca. 
300 kJ/mol (methoxyacetophenones)134 down to 290 kJ/mol 
(benzophenone and phthalimidine derivatives)31, 48, 55, 68 and 
more recently to 267 kJ/mol (FQs)71, 72. A series of 85 
fluoroquinolones (FQs), including ENX, pefloxacin (PFX), 
 
NFX, ANFX, OFX and rufloxacin (RFX) have been 
investigated to determine their potential as photosensitisers 
for Pyr<>Pyr dimers formation in DNA. At FQ concentrations 
Table 6 Rate constants of energy transfer from FQs to flurbiprofen (FBP), 4-biphenylcarboxylic acid (BPC) and naproxen (NP) and estimated values of 
the triplet excited state energies of FQs72  5 
 3ENX 3PFX 3NFX 3ANFX 3OFX 3RFX 
kET (FBP) / 10
9 (M-1s-1)a 0.3 0.09 0.09 < 0.01 < 0.01 < 0.01 
EFBP-X (kJ/mol)
b +4 +8 +8 > +8 > +8 > +8 
kET (BPC) / 10
9 (M-1s-1)a 2.3 1.7 1.5 0.9 0.02 < 0.01 
EBPC-X (kJ/mol)
b < -8 -3 -3 +1 > +8 > +8 
kET (NP) / 10
9 (M-1s-1)a 2.3 2.2 2.2 2.1 1.8 0.2 
ENP-X (kJ/mol)
b < -8 < -8 < -8 -7 -4 +6 
ET (kJ/mol)
c 273 269 269 265 262 253 
a Quenching rate constants obtained in N2O-purged medium using 0.1 to 10 mM concentrations of the quenchers. 
bE is the energy difference between the 
triplet excited states of quenchers and FQs obtained from Sandros´ equation; kET = (kmax x e 
–E/RT) / (e-E/RT + 1) assuming that kmax = 2.2 x 10
9 M-1s-
1.cEstimated values taking into account that ET of BPC and NP are ca. 266 and 259 kJ/mol, respectively 
for Pyr<>Pyr dimers formation in DNA. At FQ concentrations 
and light doses insufficient to produce direct single strand  10 
breaks, ENX, PFX and NFX are able to produce Pyr<>Pyr 
dimers in DNA as revealed by enzymatic treatment with T4 
endonuclease V. By contrast, ANFX, OFX and RFX are 
inefficient in this assay (Fig. 9). This information has been 
combined with the absolute values of the triplet energies of 15 
ENX, PFX, NFX, ANFX, OFX and RFX, estimated by means 
of LFP, using flurbiprofen (FBP), 4-biphenylcarboxylic acid 
(BPC) and naproxen (NP) as energy acceptors (Table 6).71, 72
 All the results indicate that the threshold ET value required 
for a given compound to become a potential DNA 20 
photosensitiser via Thy<>Thy formation is in the range 
defined by the triplet energies of NFX and ANFX (265-269 
kJ/mol, see Fig. 9). 
 Moreover, when the Phs ET is lower than the threshold, 
triplet quenching by Pyr derivatives can only occur by 25 
pathways not involving energy transfer. This is the case for 
menadione, whose ET is ca. 243 kJ/mol. The high quenching 
rate constants (between 1.0 and 2.5 x 109 M-1 s-1) correspond 
to electron transfer, generating menadione radical anion and 
Pyr radical cations (Scheme 3).144 30 
 As stated above, in the case of Cyt, dCyd and dCMP, the 
triplet energy is higher than that reported for Thy, Thd and 
TMP. Therefore their triplet excited states are difficult to 
detect when both types of Pyr units are present, owing to 
deactivation via base-to-base energy transfer. Nonetheless, the 35 
transient absorption spectra have been recorded using acetone 
as Phs. From this type of experiment, it has been possible to 
determine the rate constants of unimolecular decay (k0), as 
well as those of self quenching (ks) (Table 7).
133 
Table 7 Kinetic parameters of Cyt and derivatives in aqueous solutions 40 
 k0 /10
4 s-1 kS / 10
8 M-1s-1 kq1 (acetone) /10
9 M-1 s-1 
Cyt 5.5 4.2 3.8 
dCyd 7.6 2.4 4.5 
dCMP 9.4 1.8 5.1 
 
 
6. Summary and Outlook 
Triplet excited states play a key role in the dimerisation of 
pyrimidine bases, not only in photosensitised processes, but 45 
also upon direct UV-irradiation. Cyclobutane pyrimidine 
dimers (CPDs) are by far the most relevant Pyr photoproducts 
obtained by sensitisation. Spore photoproducts may also be 
formed through this pathway; however, they are not found in 
mammals or other higher organisms. By contrast, there is no 50 
evidence for photosensitised reactions leading to pyrimidine 
(6-4) pyrimidone photoproducts. The mechanism of direct 
UVA-induced CPDs formation is still controversial; as DNA 
hardly absorbs in this wavelength range, the involvement of 
endogenous photosensitisers cannot be safely ruled out.  In 55 
spite of the importance of the triplet pathway in Pyr 
photodimerisation, further efforts are needed to achieve a 
better understanding by means of theoretical calculations. 
Issues such as the lack of pyrimidine (6-4) pyrimidone 
formation or the special conditions required to obtain spore 60 
photoproducts from the triplet manifold should be explained. 
Finally, the triplet energy of thymine in DNA has been found 
to be much lower than that of the free base or the nucleoside. 
As this is a key parameter to anticipate the potential 
photocarcinogenicity of photosensitisers, it seems interesting 65 
to clarify how the various  structural features (sequence, -
stacking, base pairing, etc.) modulate its actual value in the 
different microenvironments of the biomacromolecule. 
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